Skip to content
Adam Torkildson – Lifestyle
Author:
Cardiol Therapeutics Inc. (NASDAQ: CRDL)
$30 Billion Per Year US Heart Failure Market Presents Huge Opportunity for Promising Drugs Advancing with Positive Trial Results for Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL)
April 13, 2026
←
Previous Page
1
2